Abstract:Breast cancer is still the most common cancer among women worldwide, causing a heavy burden of disease, mortality and long-term survival. In this context, women's participation in breast cancer research, especially in the leadership process, is important for increasing knowledge and developing health policy. However, gender gaps in leadership still exist. According to the 2023 OCSE report, women make up less than 30% of scientists worldwide, and their representation in senior positions and as decision-makers is even lower, especially in programs such as medical and experimental oncology. This under-representation not only hinders development of new ideas to solve complex diseases, such as breast cancer, but also impedes the progress needed to solve the specific health problems faced by women.Negative factors such as research funding bias, organizational bias, and lack of continuing education risk hindering women's advancement in scientific research. Furthermore, as a result of their significant contributions to research, female researchers should be recognized more for their contributions, leadership, and talent in relevant publications. The COVID-19 pandemic has further exacerbated inequality, negatively impacting female researchers who face greater supervisory responsibilities, thereby reducing research output. As we strive for a more social environment, it is even more important to provide platforms that support and promote the work of female scientists.The Frontiers in Oncology's Women in Breast Cancer series provides one such platform to share the diverse, valuable latest contributions of female researchers to breast cancer research. Volume III contains 21 articles covering a wide range of topics from molecular analysis and new diagnostics to clinical and patient care. These projects are all led by women and include a large number of female scientists, at various stages in their careers. Collectively, this series provides insight into the evolution of breast cancer research, providing a deeper understanding of early treatment and the biological, psychological, and treatment of the disease.Advances in breast cancer diagnostics are critical to improving early diagnosis and ensuring that patients receive the best possible treatment and personalized care. A key study in this volume investigates the ability of ultrasound-based radiography to estimate the expression of important markers such as oestrogen receptor (ER), progesterone receptor (PR), HER2, and Ki-67 in breast cancer patients (Xu et al.). This new approach aims to eliminate molecular testing, reduces the need for biopsies, and offers a more efficient, patient-friendly alternative to traditional diagnostics. These advances are particularly important for improving diagnostic accuracy and guiding treatment in different types of breast cancer.This research is complemented by another study on breast calcification, which is often an early sign of malignancy. A new machine learning algorithm was developed to improve the segmentation and quantification of calcium in mammograms (Tong et al.). The algorithm is superior in identifying microcalcifications compared to existing models, improving the diagnostic process by helping radiologists distinguish malignant diseases. This AI-powered innovation holds great promise for improving early detection and reducing misdiagnosis, especially in difficult-to-find early-stage breast tissue.Advances in decisive oncology continue to improve breast cancer treatment. Much of the research in this issue focuses on personalized treatment strategies to improve outcomes based on the patient's molecular profile. A key example is the study of the Lem-D protein in triple-negative breast cancer (TNBC) (Rose et al.). Because TNBC lacks hormone receptors that are frequently targeted by other types of breast cancer, treatments are often limited. The researchers in this volume describe the role of nuclear envelope proteins, such as Ankle2, TMPO, and Emerin in TNBC cell growth, providing compelling evidence that these proteins may serve as a new treatment plan. This opens the door to more effective, targeted interventions for one of the most serious and difficult-to-treat breast cancers.Improving of personalized therapy also include traditional treatment such as radiotherapy. Comparative studies of conventional and hypofractionated radiation therapy using the Halcyon system highlight the importance of radiation therapy to stabilize the tumour with reduced side effects (Tai et al.). The hypofractionation approach, which delivers more radiation in fewer sessions, has been shown to be better minimizing side effects, even if not as effective in controlling tumours, as than conventional ones.Breast cancer, irrespective of its extent and treatment, has negative impacts on several aspects of women's lives. This issue includes several studies that highlight the importance of health-related qual -Abstract Truncated-

Insights and solutions for advancing and empowering women in oncology from the Gulf Cooperation Council Countries

Progress in neurosurgery: Contributions of women neurosurgeons in the Middle East

Women Empowerment in Medical Imaging and Radiology: Status and Challenges

The current and future cancer burden in the Gulf Cooperation Council (GCC) countries

Current situation and barriers to women's leadership in health care education in Saudi Arabia: A cross-sectional study

Challenges and Opportunities in Breast Cancer Care in Low-Resourced Countries, Jordan as An Example

A mapping study and recommendations for a joint NGO (Think Pink) and Bahrain Government Breast Cancer project

Oncology Early-Phase Clinical Trials in the Middle East and North Africa: A Review of the Current Status, Challenges, Opportunities, and Future Directions

Knowledge, Attitudes, and Practices Toward Breast Cancer and Breast Cancer Screening Among Arab Females in the Middle East: A Literature Review

Editorial: Women in breast cancer, volume III: 2023

Accessing breast cancer care in a protracted conflict: Qualitative exploration of the perspectives of women with breast cancer in northwest Syria

Clinical Outcomes and Treatment Efficacy in Cervical Cancer Patients in the UAE: A Retrospective Cohort Study

Barriers to healthcare seeking, beliefs about ovarian cancer and the role of socio-economic position. A cross-sectional multilevel study in Dubai, a multicultural society

Solutions to Gender Balance in STEM Fields Through Support, Training, Education and Mentoring: Report of the International Women in Medical Physics and Biomedical Engineering Task Group

Saudi Women's Views on Healthcare Leadership in the Era of Saudi 2030 Health Transformation

Awareness of Breast Cancer Screening and Risk Factors among the General Female Population in the Western Province of Saudi Arabia: A Cross-Sectional Study

Exploring the Challenges in Palliative Care As Perceived by the Saudi Physicians: A Cross-Sectional Study

Short Communication: Understanding the Barriers to Cervical Cancer Prevention and HPV Vaccination in Saudi Arabia

Exploring global barriers to optimal ovarian cancer care: thematic analysis

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey

The influence of an all-female healthcare environment on mentorship and empowerment of female healthcare professionals